Loading ...

NULL_

(

TN-09 CTLA-4 Ig

)

ITN Protocol #:

ITN517AI

Branded Name:

TN-09 CTLA-4 Ig

ClinicalTrials.Gov ID:

Treatment Protocol #:

Therapeutic Area:

Type 1 Diabetes

Current Status:

ITN Website Clinical Trial Recruiting Site Document Portal Location Study on ITN TrialShare

Summary:

Effects of CTLA-4 Ig (Abatacept) On The Progression of Type 1 Diabetes In New Onset Subjects

Clinical Operations Manager

ITN Biologist

Study Personnel:

Protocol Chair

Carol Soppe csoppe@immunetolerance.org

Work:

415-353-4879

Protocol Chair

Katarzyna Bourcier kbourcier@immunetolerance.org

Work:

240-235-6152

Admin Links

Shortcuts

ITN Documents

Links